← Leaderboards
Alison Burklund
Nanopathdx, Inc.
$980,835
Attributed
$1,961,669
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $996.7K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,961,669 · 1
By mechanism
R44$1,961,669 · 1
Top collaborators
- Amogha Tadimety2 shared
Others in their field
Other Rising Stars on “Antibiotic Therapy”
- Laurene Wang · Aimmax Therapeutics, Inc.$3,663,308
- Robert Pease Smith · Tufts University Boston$3,652,652
- Nathaniel James Rhodes · Midwestern University$3,151,448
- Justin Blaine Schaal · University Of Southern California$3,025,760
- Jill Rene Stewart · University Of South Carolina At Columbia$3,000,004
- Ajit K Parhi · Taxis Pharmaceuticals, Inc.$2,799,789
Research focus
Antibiotic TherapyAntibiotic ResistanceAssay DevelopmentBacteremiaBacterial InfectionsAntimicrobial ResistanceCandidate ValidationClinically SignificantClinical ResearchClinical SensitivityCollaborationsColorCommercializationCostCoupledCross ReactivityCytolysisDesignDetectionDetection LimitDiagnosisDiagnosticDiagnostic AssayDiagnostic Platform